United States Direct-to-Consumer Genetic Testing Market is Dominated by Obesity Segment through 2028
The rising demand for nourishing food is expected to drive
the growth of the United States Direct-To-Consumer Genetic Testing Market during
the forecast period, 2024-2028.
According to the TechSci Research report, “United
States Direct-To-Consumer
Genetic Testing Market - By Region, Competition, Forecast and Opportunities,
2028”, United
States Direct-To-Consumer Genetic Testing Market is projected to grow at an
impressive rate during the forecast period, 2024-2028. The market expansion is
anticipated to be fueled by the increasing prevalence of rare genetic diseases.
Growing public awareness and rising demand for personalized genetic services
are anticipated to support Direct-To-Consumer (DTC) market expansion. The
Direct-To-Consumer (DTC) genetic testing market is fragmented, with a few of
prominent firms and other small start-up businesses offering superior quality
Direct-To-Consumer (DTC) genetic tests at lower prices, which will solve
affordability difficulties and favorably affect market growth. Furthermore, high
growth in the United States and Canada is responsible for increasing public
awareness of direct-to-consumer genetic tests. The market is also expected to
expand as people of the countries' densely populated areas utilize the internet
more frequently. Similarly, the region's market will expand if regulations are
made simpler. Hence, the above-mentioned factors drive the growth of the market
throughout the forecast period, 2024-2028.
However, factors hampering
the overall growth of the United States Direct-To-Consumer Genetic Testing
Market are high investment in technologies and low-skilled workforces to handle
sophisticated instruments. Furthermore, high investment in a manufacturing
facility and defects in DTC testing kits, along with data privacy concerns
regarding DTC genetic testing is limiting the Direct-To-Consumer Genetic
Testing market growth.
Browse over XX market data Figures spread through 70 Pages and an in-depth
TOC on the "United States Direct-To-Consumer Genetic Testing Market.”
The United States Direct-To-Consumer Genetic Testing Market is segmented based
on test type, technology, sample, and distribution channel.
Based on the test type
segment, the market is further divided into ancestry & relationship
testing, predictive testing, nutrigenomic testing, carrier testing, skincare testing,
and others. The predictive testing category is expected to register a high CAGR
in the United States Direct-To-Consumer Genetic Testing Market. This is due to
rising ongoing research and upgrades in platforms to enhance the efficiency of
the genome analysis procedure.
Based on technology, the
market is further categorized into Single Nucleotide Polymorphism (SNP) chips,
Targeted Analysis, Whole Genome Sequencing (WGS), and Others. The Single
Nucleotide Polymorphism (SNP) segment is expected to drive the growth of the
market throughout the forecast period, 2024-2028. The factor contributing to
the growth of the segment is their ability to measure both dosage change DNA
polymorphism along with various applications such as microarray analysis in
cancer research and other. Moreover, the need to minimize errors in DTC genetic
testing is expected to support the growth of the market during the forecast
period.
Based on sample, the market
is further divided into saliva/buccal swabs, blood, and others. The blood segment
is expected to hold the largest market share during the forecast period, 2024-2028.
As blood test identifies a variety of components in the body as compared to
other tests and provides accuracy in results.
Major companies operating
in the United States Direct-To-Consumer Genetic Testing Market are:
- Ancestry.com,
LLC
- Helix OpCo
LLC
- MyHeritage
Ltd.
- Living DNA
- Direct
Laboratory Services, LLC
Download Free Sample Report
Customers
can also request for 10% free customization on this report.
Based
on the distribution channel the market is further bifurcated into online and
offline. The offline segment is expected to dominate the growth of the Direct-To-Consumer
Genetic Testing market in the United States. This expansion is ascribed to an optimum
availability of DTC consumers genetic testing kits. Moreover, OTC products are
affordable, convenient, and less complex which in turn drive the growth of the
market,” said Mr. Karan Chechi, Research
Director with TechSci Research, a research-based global management consulting
firm.
“United States Direct-To-Consumer
Genetic Testing Market- By Test Type (Ancestry
& Relationship Testing, Predictive Testing, Nutrigenomic Testing, Carrier
Testing, Skincare Testing, and Others), By Technology (Single Nucleotide
Polymorphism (SNP) Chips, Targeted Analysis, Whole Genome Sequencing (WGS),
Others), By Sample (Saliva, Urine, Blood, Others), By Distribution Channel
(Online v/s Offline), By Company and By Region,
has evaluated the future growth potential of the United States Direct-To-Consumer
Genetic Testing Market and provides statistics & information on market
size, structure, and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in the United
States Direct-To-Consumer Genetic Testing Market.”
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com